#4D6D88_Small Cover_March-April 2024 DRA Journal

In this exclusive Show Preview Issue, we present the IDEM Singapore 2024 Q&A Forum featuring key opinion leaders; their clinical insights covering orthodontics and dental implantology; plus a sneak peek at the products and technologies set to take center stage at the event. 

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

Caution Urged on Meftal Usage

INDIA: In response to an alert issued by the Indian Pharmacopoeia Commission (IPC), medical experts advise caution regarding the use of Meftal, a common painkiller utilized for various conditions, including menstrual cramps, rheumatoid arthritis, and dental pain.

IPC Alert Highlights Adverse Reactions

The IPC alert emphasizes potential adverse reactions associated with Meftal, particularly due to its main composition, Mefenamic acid. The alert warns of the risk of Eosinophilia and systemic symptoms (DRESS) syndrome, a severe allergic disease recognized for its painful manifestations.

DRESS syndrome involves an extensive skin rash accompanied by organ involvement, Lymphadenopathy, Eosinophilia, and systemic manifestations. Dr. Tushar Tayal, Lead Consultant at CK Birla Hospital, Gurugram, explains the challenging nature of predicting DRESS syndrome, urging caution in over-the-counter painkiller usage.


Click to Visit website of India's Leading Manufacturer of World Class Dental Materials, Exported to 90+ Countries.


 

Risks of Mefenamic Acid as an NSAID

Mefenamic acid, classified as a nonsteroidal anti-inflammatory drug (NSAID), carries inherent risks and side effects. These include gastrointestinal issues, cardiovascular complications, and renal problems. Dr. Vikramjeet Singh from Aakash Healthcare underscores the need for caution in patients with kidney disease, epilepsy, or cardiac dysfunction.

Read: Acetaminophen and NSAIDs Recommended as First-Line Treatment for Paediatric Dental Pain, Says New Guideline

Doctors emphasize a cautious approach, advocating for the lowest effective dose for the shortest duration when administering NSAIDs like Meftal. Dr. Rashmi Baliyan from Primus Super Speciality Hospital highlights the unsuitability of Meftal for pregnant and nursing women, citing potential disruptions to blood flow to the fetus and toxicity in breast milk.

Meftal Concerns Extend to Childhood Usage

Dr. Rajath Athreya from Sakra World Hospital Bengaluru raises concerns over Meftal’s use for childhood fevers, emphasizing the lack of safety data to support its benefits. He encourages a tiered approach, prioritizing trusted medications like paracetamol and occasional ibuprofen.

The collective advice from health experts underscores the importance of seeking professional medical advice before using Meftal or any medication. They urge patients to understand potential risks and receive personalized guidance for safe usage.

As the IPC’s drug safety alert prompts increased awareness, healthcare professionals and patients are encouraged to stay informed and exercise caution in medication choices.

Read: Cannabidiol Shows Promise as Non-Opioid Analgesic in Dental Pain Management

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.

Leave a Reply

Your email address will not be published. Required fields are marked *